XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Cash flow provided by (used in) operating activities:    
Net income $ 191,530 $ 151,904
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 15,482 14,679
Stock-based compensation 14,384 13,615
Income (Loss) from unconsolidated entities 4,433 (22,037)
Distributions of earnings from unconsolidated entities 1,460 23,502
Deferred tax (benefit) provision 3,307 2,408
Inventory impairments and write-offs 8,004 2,233
Other 1,462 2,372
Changes in operating assets and liabilities    
Inventory (353,284) (565,482)
Payments for Origination of Mortgage Loans Held-for-sale (290,474) (412,955)
Sale of mortgage loans 399,744 520,370
Receivables, prepaid expenses and other assets 25,875 (6,557)
Current income taxes, net (164,463) (48,074)
Customer deposits, net (11,975) 77,618
Accounts payable and accrued expenses (216,249) (34,294)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations (357,764) (280,698)
Cash flow (used in) provided by investing activities:    
Purchase of property, construction and office equipment - net (19,738) (18,475)
Investments in and advances to unconsolidated entities (74,550) (109,866)
Return of investments in unconsolidated entities 15,866 65,792
Proceeds from the sale of assets 9,041 0
Other 0 194
Net Cash (Used in) Provided By Investing Activities, Continuing Operations (69,381) (62,355)
Cash flow used in financing activities:    
Proceeds from loans payable 703,990 766,858
Repayments of loans payable (829,134) (822,142)
Redemption of senior notes 0 (409,856)
(Payments) proceeds from stock-based benefit plans 24,857 (2,701)
Purchase of treasury stock (9,357) (128,069)
Dividends paid (22,878) (21,077)
Proceeds from (Payments to) Noncontrolling Interests 0 (61)
Net Cash Used in Financing Activities, Continuing Operations (132,522) (617,048)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (559,667) (960,101)
Cash, Cash Equivalents, and Restricted Cash , beginning of period 1,398,550 1,684,412
Cash, Cash Equivalents, and Restricted Cash, end of period 838,883 724,311
Land and Land Improvements    
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Inventory impairments and write-offs $ 13,000 $ 0